Conversion Labs, Inc. (OTCQB: CVLB)
Development, Acquisition and Commercialization of Revolutionary Healthcare Products
Conversion Labs is discovering and marketing innovative consumer products that address large unmet needs in the market. New product opportunities are everywhere, yet few companies have the expertise to recognize gaps; source products that can fill those gaps; and commercialize these new products in a rapid, scalable approach that doesn’t require large amounts of capital.
Conversion Labs proven track record is the result of a diverse leadership team comprised of individuals with experience in product licensing, online advertising, direct-response marketing, mergers & acquisitions, and private equity. With our in-house marketing team, we test, optimize, adapt and scale our marketing campaigns rapidly and efficiently, for quick proof of concept and return on investment.
PDF COMPANY PRESENTATION:
OUR 5 BRANDS:
For the six months ended June 30, 2018, revenues grew to $3.644 Million, or 340% compared to the same period in 2017. Gross profits rose 396% to $2.753 Million, as a result of higher revenues and lower costs.
1. ShapiroMD, which propelled near 400% growth in gross profit,
2. INR Wellness and
3. PDF Simpli - both of which launched this past quarter -
4. Scarology and
5. Purpurex, which are expected to be launched in the third and fourth quarter of this year, respectively.
We anticipate our growth will push us into profitability towards the end of the third quarter of 2018," stated Justin Schreiber, President and CEO of Conversion Labs, Inc.
To learn more, visit www.conversionlabs.com.
Restricted 14,427,139 09/07/2018
Unrestricted 30,523,789 09/07/2018
Held at DTC 27,038,612
Float 13,990,119 08/15/2016
Shareholders of Record 325 04/02/2018
Justin Schreiber CEO
Stefan Galluppi CTO
|Symbol Change ||06/22/2018 ||CVLB ||Symbol change from IMMD to CVLB |
OTCQB Member Since 05/2015
U.S. Reporting: SEC Reporting
Audited Financials Audited Latest Report 06/30/2018
John Strawn Chairman,
SIC - Industry Classification
2833 - Medicinal and botanicals
Formerly=ImmuDyne, Inc. until 6-2018
Formerly=Anina Resources, Inc to 11-87
OTC DISCLOSURE & NEWS SERVICE
Moderator's Disclaimer - This board is for CVLB discussion purposes only and is in no way a recommendation to buy or sell. Any investment decisions should be based on your own due diligence and decision. You are solely responsible for your choices to buy or sell.